Downregulation of PHLPP induced by endoplasmic reticulum stress promotes eIF2α phosphorylation and chemoresistance in colon cancer

Cell Death Dis. 2021 Oct 18;12(11):960. doi: 10.1038/s41419-021-04251-0.

Abstract

Aberrant activation of endoplasmic reticulum (ER) stress by extrinsic and intrinsic factors contributes to tumorigenesis and resistance to chemotherapies in various cancer types. Our previous studies have shown that the downregulation of PHLPP, a novel family of Ser/Thr protein phosphatases, promotes tumor initiation, and progression. Here we investigated the functional interaction between the ER stress and PHLPP expression in colon cancer. We found that induction of ER stress significantly decreased the expression of PHLPP proteins through a proteasome-dependent mechanism. Knockdown of PHLPP increased the phosphorylation of eIF2α as well as the expression of autophagy-associated genes downstream of the eIF2α/ATF4 signaling pathway. In addition, results from immunoprecipitation experiments showed that PHLPP interacted with eIF2α and this interaction was enhanced by ER stress. Functionally, knockdown of PHLPP improved cell survival under ER stress conditions, whereas overexpression of a degradation-resistant mutant PHLPP1 had the opposite effect. Taken together, our studies identified ER stress as a novel mechanism that triggers PHLPP downregulation; and PHLPP-loss promotes chemoresistance by upregulating the eIF2α/ATF4 signaling axis in colon cancer cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 4 / metabolism
  • Autophagy / drug effects
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / genetics*
  • Colonic Neoplasms / pathology*
  • Down-Regulation / genetics*
  • Drug Resistance, Neoplasm* / genetics
  • Endoplasmic Reticulum Stress* / drug effects
  • Endoplasmic Reticulum Stress* / genetics
  • Eukaryotic Initiation Factor-2 / metabolism*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Irinotecan / pharmacology
  • Irinotecan / therapeutic use
  • Nuclear Proteins / genetics*
  • Nuclear Proteins / metabolism
  • Phosphoprotein Phosphatases / genetics*
  • Phosphoprotein Phosphatases / metabolism
  • Phosphorylation
  • Proteasome Endopeptidase Complex / metabolism
  • Proteasome Inhibitors / pharmacology
  • Protein Binding / drug effects
  • Signal Transduction / drug effects
  • Tunicamycin / pharmacology
  • Tunicamycin / therapeutic use

Substances

  • Eukaryotic Initiation Factor-2
  • Nuclear Proteins
  • Proteasome Inhibitors
  • Tunicamycin
  • Activating Transcription Factor 4
  • Irinotecan
  • PHLPP1 protein, human
  • Phosphoprotein Phosphatases
  • Proteasome Endopeptidase Complex